1 / 1

Acute Respiratory Distress Syndrome (ARDS) Market

In 2017, the total incident population of Acute Respiratory Distress Syndrome (ARDS) in the 7MM was 7,99,872, out of all the incidence cases in seven major markets, the US accounts for about 4,95,655 cases.<br><br>The market size of Acute Respiratory Distress Syndrome (ARDS) in the 7MM is expected to grow at a CAGR of 9.55% during the study period (2017-2030).<br><br>The key pharma players in the Acute Respiratory Distress Syndrome (ARDS) market includes Faron Pharmaceuticals, Biomarck Pharmaceuticals, Athersys, Inc, Alexion Pharmaceuticals, Apeptico, and many others.<br><br>For more detailed information on Acute Respiratory Distress Syndrome (ARDS) Market, visit: <br>https://www.delveinsight.com/report-store/acute-respiratory-distress-syndrome-ards-market<br>#RespiratoryDisease #respiratoryfailure #ARDS #AcuteRespiratoryDistressSyndrome #sepsis<br>#acutelunginjury #alveolarinjury #lunginjury #respiratoryfailure<br><br>

DelveInsight
Télécharger la présentation

Acute Respiratory Distress Syndrome (ARDS) Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    More Related